US Stock MarketDetailed Quotes

CMND Clearmind Medicine

Watchlist

1.0800
0.00000.00%

Close Mar 26 16:00 ET

1.0806
+0.0006+0.06%

Post 17:25 ET

5.55MMarket Cap-1.05P/E (TTM)

Clearmind Medicine Stock Forum

Stock_Drift

Mar 21 23:36

$Clearmind Medicine (CMND.US)$

Teddy123

Mar 21 21:30

Clearmind Medicine’s FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones

$Clearmind Medicine (CMND.US)$
Major Breakthrough: Yale and Johns Hopkins to Test New Alcohol Disorder Treatment in FDA Trial

Jaguar8

Mar 21 21:28

NEWS

$Clearmind Medicine (CMND.US)$
Clearmind Medicine's FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones
Friday, 21st March at 9:28 am
Vancouver, Canada, March 21, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, ann...

Teddy123

Mar 19 21:22

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

$Clearmind Medicine (CMND.US)$
Revolutionary Intranasal System Could Transform Psychedelic Drug Treatment Delivery

Teddy123

Mar 18 19:40

Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients

$Clearmind Medicine (CMND.US)$
Breakthrough AUD Treatment Enters Human Trials: Yale, Johns Hopkins Back Clearmind's Novel Therapy

Jaguar8

Mar 10 22:05

NEWS

$Clearmind Medicine (CMND.US)$ $SciSparc (SPRC.US)$
Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea
Monday, 10th March at 7:27 am
Vancouver, Canada, March 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems,...

Teddy123

Mar 10 19:30

Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea

$Clearmind Medicine (CMND.US)$
Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea

Jaguar8

Feb 4 21:35

NEWS

$Clearmind Medicine (CMND.US)$ $SciSparc (SPRC.US)$
Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico
Tuesday, 4th February at 8:35 am
Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, annou...

SevenTee

Jan 7 01:42

it’s not over

$SciSparc (SPRC.US)$ if yall read my DD they have an acquisition with $N2OFF (NITO.US)$ being announced soon for the subsidiary Mitocare. That deal is for $700k cash and $4.3 million of NITO shares priced at .70. The news today for the collaboration with $Clearmind Medicine (CMND.US)$ was to give SPRC its own legs to stand on so it wouldnt be too reliant on NITOs success while holding such a large amount of shares.
this is just the beginning….